Excellence for the Future, State Securities Regulation Award), Co-Leader Healthcare Private Equity Practice, Representative Healthcare Private Equity and Strategic Transactions, Healthcare Private Equity, Strategic Transactions and Regulatory, Privacy, Security, and Information Technology, Health Care M&A Activity Remains Immune to COVID-19, $3.1 billion sale of a national assisted living company*, $1 billion sale of a national long-term care pharmacy chain to a private equity sponsor*, $1 billion+ sale of a group purchasing organization*, $750 million+ equity investment in an outpatient pharmacy management company*, $500 million+ acquisition of an inpatient pharmacy management company*, Sale of cannabis company to multinational public cannabis company*, $500 million+ merger of national oncology groups*, $300 million+ acquisition and consolidation of staffing company*, $500 million+ acquisition of a national pharmacy*, $500 million+ recapitalization of specialty and LTC pharmacies*, $500 million+ sale of medical device company to a financial sponsor*, $400 million+ financial sponsor investment in a PBM*, $500 million+ financial sponsor acquisition of veterinary practices and roll-up*, $250 million+ group purchasing organization roll-ups**, Several complex, $1billion+ REIT, skilled nursing facility and ALF acquisitions in Texas and Louisiana*, $200 million+ acquisition of specialty pharmacy by a financial sponsor*, $100 million+ financial sponsor acquisition of home care company and subsequent roll-up*, $100 million+ physical therapy acquisition and roll-ups*, $100 million+ sale of specialty pharmacy to a financial sponsor*, $150 million+ sale of behavioral health pharmacy to a financial sponsor*, $100 million+ sale of childrens dental platform to financial sponsor*, $100 million+ acquisition of retail pharmacy chain by a strategic*, $50 million+ sale of revenue cycle management company to financial sponsor*, Multi-million dollar health system physician roll-ups*, Cleveland Clinics formation of the first clinically based GPO*, Cancer hospital disposition of cancer center*, Complex supply chain and GPO strategic transaction for Walgreens*, Senior Care Centers (TX) in several complex, $100 million+ strategic transactions in the skilled nursing facility and post-acute care space, including pharmacy and home health*, $100 million+ sale of a urology practice management company*, $125 million+ sale of a rehabilitation provider*, Private equity sponsors investment in a radiology services company*, $100 million+ acquisition of ambulance services company*, Multiple physician joint ventures with a national dialysis provider*, $100 million+ sale of dental practice management company*, $150 million+ consolidation and sale of OB/GYN practice management company*, $100 million+ merger of national pharmacies*, $25 million+ acquisition of telepharmacy/health company by a financial sponsor*, Complex specialty pharma and supply chain transaction for Novartis*, Significant national and regional health systems affiliations and dispositions*, Supply chain, GPO and PSAO transactions for AmerisourceBergen*, Advised physician groups (including orthopedics, dermatology, behavioral health, dental, radiology, urology, podiatry, primary care, oncology, emergency medicine, gastroenterology, fertility, womens health, dialysis, nursing, veterinary, ophthalmology, pain management, and ENT) in several $100 million+ physician practice management deals with financial sponsors and strategics*, Complex supply chain transaction for Mayo Clinic*, Several $50 million+ provider/supplier acquisitions and dispositions*, Formation of national GPO among 5 health systems*, Affiliation between largest national childrens hospital GPO and national GPO*, Counseled senior care, personal care, CCRCs, independent living, ALFs and group homes on strategic transactions and regulatory matters*, Counseling largest national outpatient pharmacy management company on equity investment by Welsh Carson and Walgreen Co.*, Counseling one of the largest institutional pharmacies on sale transaction*, Counseling financial sponsors and strategic investors on mergers, acquisitions and dispositions and complex federal and state health care regulatory issues impacting M&A transactions*, Counseling private equity sponsor in connection with acquisition of Comprehensive Pharmacy Services*, Counseling private equity fund regarding exit strategies and disposition of equity interest in managed care organization joint venture*, Counseling private equity fund on health care regulatory issues impacting disposition of equity interest in group purchasing organization*, Counseling private equity fund on health care regulatory issues impacting acquisition of third-party administrator and underwriting and claims services company add-on*, Establishing buy-sell arrangements for various corporations and partnerships and other strategics, including all participants in the medical and pharmaceutical supply chain*, Counseling Summit Health in its combination with WellSpan*, Counseling hospitals on affiliations, acquisitions, and dispositions, including the affiliation of Hanover Healthcare PLUS, a community health care network in central Pennsylvania that includes the 93-bed Hanover Hospital, in its affiliation with UPMC Pinnacle, the largest health system in the state*, Counseling national and regional health systems, physician groups, long-term care facilities, and other providers on regulatory matters, including fraud and abuse, Stark, facility licensure and operations, reimbursement, including Medicare and Medicaid payment, managed care contracting, physician credentialing and termination, and contract issues, including exclusive contracts*, Counseling medical device manufacturer of health care regulatory issues in connection with initial public offering*, Counseling physician and non-physician investors in multispecialty ASC private placement*, Advising health care staffing company regarding structure, formation and contractual issues, as well as health care regulatory and malpractice matters*, Counseling second largest dialysis provider in the world on payment and reimbursement issues under government and commercial payment programs*, Advising physician groups in establishing independent physician association, hospital-physician joint ventures, provider networks, multiservice organizations, and ancillary service corporations*, Counseling pharmaceutical manufacturers regarding fraud and abuse issues, including those presented under sales and marketing arrangements, consulting agreements, and arrangements with health care professionals*, Advising ASCs, specialty hospitals and outpatient diagnostic centers on regulatory compliance issues under federal and state fraud and abuse laws (including the federal Anti-Kickback Statute), anti-referral laws (including Stark), licensure and securities laws arising from physician and non-physician, including hospital, ownership of these centers and related real estate acquired through a private offering of partnership interests*, Advising product developer on health care regulatory issues through acquisition, private placement, public offering, and commercialization matters*, Counseling suppliers and vendors in connection with fraud and abuse and health care regulatory issues impacting their businesses and arrangements with other health care organizations and individual providers*, Advising hospitals and other health care organizations in connection with establishing and/or joining group purchasing organizations*, Advising public medical transcription services company on health care regulatory issues impacting its business, including issues under the federal Anti-Kickback Statute and civil monetary penalties law*, Counseling rehabilitation center on formation and structural issues and state and federal health care regulations, including fraud and abuse, anti-referral laws, professional licensure regulations, and fee splitting statutes*, Representing hospitals and health systems in connection with managed care payment issues, standard of care, and utilization review procedures*, Assisting health systems, physicians and other providers in formulating and executing managed care business strategies, purchase and sale of physician practices, formation and operation of ancillary joint ventures, and mergers and acquisitions*, Advising lenders in connection with certain health care regulatory issues (including Stark, fraud and abuse, and HIPAA) impacting acquisitions and joint ventures*, Counseling largest long-term care pharmacy GPO on fraud and abuse issues, safe harbor regulations, and regulatory issues impacting its relationships with other members in the medical supply chain, including manufacturers, suppliers, and pharmacies*, Advising Medicare Part D pharmacy network manager on rebate, discount and PDP issues under Medicare Prescription Drug, Improvement, and Modernization Act of 2003*, Counseling multispecialty physician group on development of specialty hospital and private placement*, Counseling national retail and long-term care pharmacy chain regarding state and federal health care regulatory issues impacting its business and negotiate and draft agreements with vendors and suppliers*, Counseling private multisite radiology practice on federal and state fraud and abuse, Stark, fee splitting, licensure and government and private payor reimbursement issues*, Advising providers, including hospitals, physician groups, and medical device companies on billing and claims issues, draft corporate compliance programs and procedures, and assist with implementing plan and monitoring compliance*, Advising manufacturers, medical device companies, physician practice groups, hospitals, and other providers and suppliers on the federal Anti-Kickback Statute and Stark (and safe harbors) in connection with marketing programs, physician recruitment deals and discount, and rebate arrangements*, Counseling nonprofit hospital on disposition of its equity interest in cancer center*, Structuring strategic alliances, partnering arrangements and collaborations both in traditional health care and life sciences space*, Advising startups and emerging health care businesses on corporate formation, structure, governance and compliance issues*, Advising specialty multi physician groups on fraud and abuse and marketing guidelines, including structuring plans and programs under civil monetary penalties law and federal Anti-Kickback Statute*, Counseling biotech and manufacturers in life sciences space on wholesale distribution and GPO contracting*, Counseling biotechnology companies on strategic alliances and partnering arrangements with big pharma*, Counseling academic institutions, research organizations and biotechnology companies on clinical research issues*, Counseling research sponsors in connection with clinical trials, research and development procedures, and compliance with FDA and HIPAA regulations*, Drafting clinical trial documents and agreements, including master services agreements, clinical study agreements, protocols, agreements with CROs, confidentiality agreements, informed consent, and authorization forms*, Counseling emerging life science business on raising funds in private placement and additional rounds of financing*, Advising research organizations on indemnification, regulatory compliance, and safe harbor issues under fraud and abuse and anti-referral laws*, Advising physician network on data use rights and monetization with pharma manufacturers*, Advising health care systems, providers and vendors in connection with interpretation and implementation of HIPAA privacy, security and transaction and code set regulations, including development of privacy policies, notices, authorizations, and business associate and data use agreements*, Assisting software vendors in structuring and developing tools for transactions and claims processing and electronically exchanging protected health information in compliance with HIPAA and development of direct data entry systems*, Assisting in structuring and developing of systems (including debit card payment systems) for health care payment incompliance with HIPAA*, Counseling hospitals and health systems, providers and suppliers on e-commerce issues, including health care regulatory issues (such as fraud and abuse) impacting web-site development and hosting arrangements*, Advising parties concerning complex commercial transactions involving research and development, product launch, and product life cycle*, Advising vendors on development and commercialization of technology innovations, including disease management, charity care, prescription drug plan, and electronic health records tools*, Structuring business process outsourcing transactions, including accounting, billing, and practice management*, Advising software vendors on HIPAA and state law privacy and confidentiality compliance issues impacting electronic health records and the nuances presented by HIV/AIDS, mental health, and drug and alcohol records*, Assisting CROs and product and device manufacturers in development of protocols, research, and investigator agreements and informed consent and authorizations in compliance with HIPAA*, Counseling educational institutions regarding obligations under HIPAA privacy regulations*, Advising health care systems on privacy and security aspects of computer systems, networks, and data, including HIPAA review and drafting policies and procedures in connection with use of technology*, U.S. District Court for the Middle District of Pennsylvania, Best of the Bar, Philadelphia Business Journal, 2021, Health Care M&A Lawyer of the Year, America M&A Atlas Awards, 2019, USA Private Equity Deal of the Year, 2019, Listed in Chambers USA: Americas Leading Lawyers for Business/Private Equity-Healthcare, Speaker, Long-Term Care Pharmacy Services to At-Home LTC Patients, ASHP 2022 Midyear Clinical Meeting & Exhibition, December 7, 2022, Speaker, Mergers and Acquisitions and the Regulatory Landscape in the Post-Acute Provider Space, Premier Continuum 2022 National Meeting, November 14, 2022, Speaker, Long-Term Care Pharmacy Services to At-Home LTC Patients, American Society of Consultant Pharmacists (ASCP) 2022 Annual Meeting & Exhibition, November 5, 2022, Panelist, Lets Make a Deal: Ensuring a Smooth Transaction, National Association of Specialty Pharmacy (NASP) Annual Meeting and Expo, September 19, 2022, Speaker, Where Are the Best Healthcare Deals Today?, ACG NY Healthcare Conference, June 22, 2022, Moderator, Long Term M&A Mindset: Buy, Sell or Exit? LTC 100 Leadership Conference 2022, May 24, 2022, Panelist, Healthcare: Specialty Practices, USA Growth & Deals, 4th Annual Forum, May 4, 2022, Panelist, Healthcare M&A, 13th Annual Americas M&A Atlas Growth & Deals Forum, January 26, 2022, Speaker, Strategies and Legal Issues Concerning Senior Living and Post-Acute Mergers and Acquisitions, Oregon Health Care Association (OHCA) Annual Convention, November 10, 2021, Moderator, Hospital & Other Providers Roundtable, 13th Annual Investment and M&A Opportunities in Healthcare Conference, September 20, 2021, Panelist, State of the Healthcare M&A Industry, 13th Annual Investment and M&A Opportunities in Healthcare Conference, September 20, 2021, Panelist, Smartest M&A and Development Strategies in the COVID SNF Bust, LTC 100 Leadership Conference, May 9-12, 2021, Speaker, Deals Outlook: Healthcare Trends, Global M&A Network: USA Growth & Deals Annual Intelligence Forum, May 25-26, 2021, Moderator, Track 2: Investors Panel: Where are investors placing their bets? ACG New York 13th Annual Healthcare Conference, February 25-26, 2021, Speaker, Compliance Issues Facing Hospital-Based Specialty Pharmacies, American Society of Health-System Pharmacists (ASHP) Midyear 2020 Clinical Meeting and Exposition, December 6-10, 2020, Speaker, Sector Review: Healthcare M&A, Americas Growth and Deals Forum, November 16, 2020, Speaker, Specialty Pharmacy Services to At-Home Patients, NASP 5th Annual Specialty Law Conference, September 14, 2020, Speaker, The Oregon Health Care Association Board of Directors Retreat, July 15, 2020, Conference Planner, ACG 12th Annual Healthcare Conference, February 27, 2020, Speaker, Private Equity: Deals, Strategists and Value Creation, Global M&A Networks Americas Growth and Deals 11th Intelligence Forum, October 24, 2019, Speaker, Compliance Issues Facing Hospital-Based Specialty Pharmacies, NASP Fourth Annual Specialty Pharmacy Law Conference, September 12, 2019, Presenter, Current State of the DSO Market, Webinar Co-hosted by Provident Healthcare Partners and Pepper Hamilton, April 25, 2019, Speaker, Stark Law and the Anti-Kickback Statute: Challenges, Pitfalls and Safe Harbors, The Knowledge Group Webcast, April 2, 2019, Co-Author, Protecting Your Company From Increased Scrutiny After Release of ARCOS Opioid Data, Pepper Hamilton Client Alert, August 22, 2019. OraSure Technologies, Monte Wiltse Apply to Store Manager, Legal Secretary, Logistics Specialist and more! In addition, she advises clients on a variety of corporate governance and securities law matters. Sara Merken reports on privacy and data security, as well as the business of law, including legal innovation and key players in the legal services industry. Law firm Goodwin hires 14-partner Troutman Pepper group, Law firm Goodwin Procter cuts lawyers and staff amid shrinking demand. Our Standards: The Thomson Reuters Trust Principles. Law firm Goodwin hires 14-partner Troutman Pepper group. Browse an unrivalled portfolio of real-time and historical market data and insights from worldwide sources and experts. Chairman, President & CEO There is more to the comparison, and in the sections below, we discuss why we believe EL stock will offer better returns than PG stock in the next three years. John has handled transactions ranging in size from several million to more than $3 billion, and his experience handling white collar matters including audits and investigations helps clients to anticipate and minimize deal risk. WebOur globally recognized Life Sciences practice is uniquely positioned to partner with innovators and investors operating in a fast-moving, tech-driven environment.. With more than 230 dedicated lawyers across all major life sciences hubs in the US, Europe, and Asia, we work with life sciences companies throughout the corporate lifecycle from startup All quotes delayed a minimum of 15 minutes. CSL Behring, Kathleen Shay (Secretary) Doris Kearns Goodwin: I Think Its Time For Trump To Go, A Discussion With Procter & Gambles Chief Sustainability Officer: How Global Corporations Are Evolving Their Roles To Help Solve The Plastic Waste Crisis, Heres A Better Pick Over Procter & Gamble Stock, Ten Commonly Overlooked Investment Opportunities In Commercial Real Estate, Procter & Gamble Reports Before The Open On 4/21 -- Options Contracts Expire The Same Day, This Pharmaceuticals Company Looks To Be A Better Pick Over Procter & Gamble Stock, Mielle Organics Co-Founders On Remaining True To Customers With Procter & Gamble Acquisition, Consistent Sales Growth Has Helped Procter & Gamble Stock To Match The Market Returns, Ex-Dividend Reminder: WD-40, Procter & Gamble And Colgate-Palmolive, Procter & Gamble Stock Has Outperformed The S&P 500 Since 2017 End: Heres Why, Procter & Gamble Partners With Microsoft To Transform And Accelerate Digital Manufacturing, Do Not Sell or Share My Personal Information, Limit the Use of My Sensitive Personal Information. Use Forbes logos and quotes in your marketing. He is a former member of the adjunct faculty at Drexel University Kline School of Law and established and taught the Health Law Practicum in the Health Law Concentration to upper-level students. Actuated Medical, Tara Muzsi John W. Jones is a partner in the Private Equity group at Goodwin and a Co-Leader of the Firms Healthcare Private Equity practice. He joined the firm in 2023. Mielles founding couple shares how the P&G acquisition will expand access to women's hair product innovations for Black and Brown communities, the joint philanthropic collaboration that aims to pay things forward, and words of wisdom for the next generation of entrepreneurs in the hair industry.
Goodwin Officially Enters Philadelphia with 14 Top 20 US firm Goodwin Procter has secured a group of 14 partners from Troutman Pepper to officially launch in Philadelphia. Rachael M. Bushey is a partner in the Life Sciences group at Goodwin and Co-Chair of Goodwins Philadelphia office.
Miranda Hooker Goodwin Philadelphia, Pennsylvania 19103 United States. US Head Vaccine Public Affairs and Advocacy Try our Advanced Search for more refined results.
Professor in Bioengineering, Julian Ritchey (Chairman-Elect) Goodwins appellate practice, which is anchored in the Washington, DC office, is nationally recognized and boasts several US Supreme Court wins in recent years. Partner Bristol Myers Squibb Company, Evan Facher
Goodwin And I dont think theyre going to say yes.. WebDec 2019 - Jan 20233 years 2 months. He represents issuers and underwriters in a variety of corporate finance transactions, including initial public offerings and other public and private offerings of debt, equity, and preferred securities. Vice President Sales & Marketing, Gastroenterology The Boston-founded firm has quietly hired lawyers in cities including Atlanta, Dallas, Houston, Miami, Philadelphia, Hartford, He joined the firm in 2023. Retired CEO and former Chairman WebWhen it comes to areas like tech, life sciences and private equity, Boston-based Goodwin is among the best of the best. Partner, Strategic Growth Markets By James Boyle (March 1, 2022, 3:36 PM EST) -- Goodwin Procter LLP has expanded its transactional team with the addition of a private equity partner who joined the firm's Washington, D.C., office working remotely from Philadelphia. Access to case data within articles (numbers, filings, courts, nature of suit, and more. Senior Reporter.
Philadelphia | Locations | Goodwin Procter Find jobs. Michael Bozik, M.D. WebAlumni. WebLife Sciences Partner & Co-managing partner, Philadelphia office Goodwin Procter. Access unmatched financial data, news and content in a highly-customised workflow experience on desktop, web and mobile. Goodwin said Wednesday that it added partners Allison Nicklin, Alicia Palladino, Justin Platt and Laura Umbrecht in New York and Philadelphia from Troutman Pepper. P&G has teamed up with Microsoft to pilot innovations in cloud, AI, and digital transformation across its diaper and paper towel manufacturing units.
Abe Kwon | LinkedIn * Denotes experience prior to joining Goodwin. Looking at stock returns, both PG and TMUS, with 0% to 1% returns this year, have underperformed the broader S&P500 index, up 16%. 820 followers 500+ connections. Legal.
Grand Rapids Board Of Education Website,
Symbiosis Medical College Pune Mbbs Cut Off,
Virgin Pulse Member Login Issues,
No Hoa - Homes For Rent Near Me,
University Of Utah Farmington Pharmacy,
Articles G